Optherion Pharmaceutical Presentations at ARVO 2009
April 30, 2009
Optherion, Inc., a company developing novel molecular diagnostics and treatments for dry and wet Age-related Macular Degeneration (AMD) and other chronic diseases involving the alternative complement system, announced that it will be reporting data from its diagnostics development program at ARVO 2009.
The title of the poster presentation is “A Clinical Study to Identify a Population with Blood-Based Biomarkers for Age-Related Macular Degeneration (AMD).”
Read the full release.
Jump down to form below to submit your own comments